Lingxi Xing
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- Nanoplatforms for cancer theranostics 8
-
- Nanoparticle-Based Drug Delivery 8
- Co-authors
- Xiangyang Shi (9 shared papers)Xin Li (8 shared papers)Mingwu Shen (5 shared papers)Lianfang Du (3 shared papers)Ping Wei (1 shared paper)Lingdan Kong (2 shared papers)Benqing Zhou (2 shared papers)Andrij Pich (3 shared papers)
In The Last Decade
Lingxi Xing
16 papers receiving 933 citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Biomaterials 345
- Biomedical Engineering 566
- Materials Chemistry 274
- Molecular Medicine 26
- Oncology 130
Countries citing papers authored by Lingxi Xing
This map shows the geographic impact of Lingxi Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingxi Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingxi Xing more than expected).
Fields of papers citing papers by Lingxi Xing
This network shows the impact of papers produced by Lingxi Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingxi Xing. The network helps show where Lingxi Xing may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingxi Xing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 186 | |
| 2 | 2017 | 100 | |
| 3 | 2017 | 90 | |
| 4 | 2016 | 85 | |
| 5 | 2021 | 71 | |
| 6 | 2021 | 58 | |
| 7 | 2021 | 56 | |
| 8 | 2016 | 51 | |
| 9 | 2021 | 51 | |
| 10 | 2016 | 44 | |
| 11 | 2016 | 42 | |
| 12 | 2016 | 32 | |
| 13 | 2019 | 30 | |
| 14 | Plant-derived paclitaxel-loaded ultra-small Fe₃O₄ nanoparticles for MR imaging-mediated antitumor therapy Hit paper breakdown → | 2025 | 21 |
| 15 | 2022 | 15 | |
| 16 | Imaging findings of bile duct hamartomas: a case report and literature review. | 2015 | 13 |
| 17 | 2024 | 0 | |
| 18 | 2025 | 0 | |
| 19 | 2024 | 0 |
About Lingxi Xing
Lingxi Xing is a scholar working on Biomedical Engineering, Biomaterials, Molecular Biology, Oncology and Surgery, having authored 19 papers that have together received 945 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (8 papers), Peptidase Inhibition and Analysis (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Extracellular vesicles in disease (2 papers), RNA Interference and Gene Delivery (2 papers), Advanced Nanomaterials in Catalysis (1 paper) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Biomaterials (345 citations), Biomedical Engineering (566 citations), Materials Chemistry (274 citations), Molecular Medicine (26 citations) and Oncology (130 citations). Lingxi Xing has collaborated with scholars based in China, Portugal and Germany. Frequent co-authors include Xiangyang Shi, Xin Li, Mingwu Shen, Lianfang Du, Ping Wei, Lingdan Kong, Benqing Zhou, Andrij Pich, Lizhou Lin and Yong Hu. Their work appears in journals such as ACS Applied Materials & Interfaces, Bioactive Materials, Oncotarget, Journal of Advanced Research and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.